Observation, laser photocoagulation or anti-VEGF therapy in the management of retinal arterial macroaneurysms

Abstract Background To explore the efficacy of observation, laser photocoagulation, and anti-VEGF in the management of retinal arterial macroaneurysm (RAM). Methods We retrospectively included patients diagnosed with RAM at the Peking Union Medical College Hospital (PUMCH) from 2003 to 2021, and com...

Full description

Bibliographic Details
Main Authors: Yuelin Wang, Hong Du, Xinyu Zhao, Lihui Meng, Youxin Chen
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Ophthalmology
Subjects:
Online Access:https://doi.org/10.1186/s12886-022-02641-2
_version_ 1811233678130413568
author Yuelin Wang
Hong Du
Xinyu Zhao
Lihui Meng
Youxin Chen
author_facet Yuelin Wang
Hong Du
Xinyu Zhao
Lihui Meng
Youxin Chen
author_sort Yuelin Wang
collection DOAJ
description Abstract Background To explore the efficacy of observation, laser photocoagulation, and anti-VEGF in the management of retinal arterial macroaneurysm (RAM). Methods We retrospectively included patients diagnosed with RAM at the Peking Union Medical College Hospital (PUMCH) from 2003 to 2021, and comprehensively reviewed cases documented in the literature from multiple databases (PROSPERO protocol CRD42022310417). Patients were categorized into 3 groups: the observation group, anti-VEGF group, and laser photocoagulation group. LogMAR visual acuity (VA) and central retinal thickness (CMT) at the end of the follow-up were analyzed. Results A total of 14 patients from the PUMCH and 210 patients from the literature review were included. VA and CMT in patients who underwent observation, laser photocoagulation, and anti-VEGF therapies were significantly improved from baseline (p < 0.05), with changes in LogMAR VA improved by -0.34 ± 0.68, -0.17 ± 0.58, and -0.45 ± 0.62 and changes in CMT improved by -148.26 ± 138.99 µm, -185.61 ± 130.37 µm, and -287.45 ± 171.87 µm, respectively. Subgroup analysis revealed that anti-VEGF therapy was used in patients with worse VA than patients who underwent laser photocoagulation (p = 0.010), but achieved better improvement in VA than the laser photocoagulation group (p = 0.049). Patients treated with anti-VEGF also had thicker CMT than the observation group (p = 0.013), and experienced better changes in CMT than the observation, as well as laser photocoagulation groups (p = 0.005; p = 0.047). Conclusion Observation, anti-VEGF, and laser photocoagulation are effective therapeutic methods for the management of RAM, and anti-VEGF therapy is intended to better improve patients with severe VA and CMT.
first_indexed 2024-04-12T11:23:44Z
format Article
id doaj.art-c3077e88b30a4b1fbc0f447c9399e40d
institution Directory Open Access Journal
issn 1471-2415
language English
last_indexed 2024-04-12T11:23:44Z
publishDate 2022-11-01
publisher BMC
record_format Article
series BMC Ophthalmology
spelling doaj.art-c3077e88b30a4b1fbc0f447c9399e40d2022-12-22T03:35:17ZengBMCBMC Ophthalmology1471-24152022-11-012211910.1186/s12886-022-02641-2Observation, laser photocoagulation or anti-VEGF therapy in the management of retinal arterial macroaneurysmsYuelin Wang0Hong Du1Xinyu Zhao2Lihui Meng3Youxin Chen4Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical SciencesDepartment of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical SciencesDepartment of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical SciencesDepartment of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical SciencesDepartment of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical SciencesAbstract Background To explore the efficacy of observation, laser photocoagulation, and anti-VEGF in the management of retinal arterial macroaneurysm (RAM). Methods We retrospectively included patients diagnosed with RAM at the Peking Union Medical College Hospital (PUMCH) from 2003 to 2021, and comprehensively reviewed cases documented in the literature from multiple databases (PROSPERO protocol CRD42022310417). Patients were categorized into 3 groups: the observation group, anti-VEGF group, and laser photocoagulation group. LogMAR visual acuity (VA) and central retinal thickness (CMT) at the end of the follow-up were analyzed. Results A total of 14 patients from the PUMCH and 210 patients from the literature review were included. VA and CMT in patients who underwent observation, laser photocoagulation, and anti-VEGF therapies were significantly improved from baseline (p < 0.05), with changes in LogMAR VA improved by -0.34 ± 0.68, -0.17 ± 0.58, and -0.45 ± 0.62 and changes in CMT improved by -148.26 ± 138.99 µm, -185.61 ± 130.37 µm, and -287.45 ± 171.87 µm, respectively. Subgroup analysis revealed that anti-VEGF therapy was used in patients with worse VA than patients who underwent laser photocoagulation (p = 0.010), but achieved better improvement in VA than the laser photocoagulation group (p = 0.049). Patients treated with anti-VEGF also had thicker CMT than the observation group (p = 0.013), and experienced better changes in CMT than the observation, as well as laser photocoagulation groups (p = 0.005; p = 0.047). Conclusion Observation, anti-VEGF, and laser photocoagulation are effective therapeutic methods for the management of RAM, and anti-VEGF therapy is intended to better improve patients with severe VA and CMT.https://doi.org/10.1186/s12886-022-02641-2Retinal arterial macroaneurysmManagementClinical characteristicsVisual acuityCentral retinal thickness
spellingShingle Yuelin Wang
Hong Du
Xinyu Zhao
Lihui Meng
Youxin Chen
Observation, laser photocoagulation or anti-VEGF therapy in the management of retinal arterial macroaneurysms
BMC Ophthalmology
Retinal arterial macroaneurysm
Management
Clinical characteristics
Visual acuity
Central retinal thickness
title Observation, laser photocoagulation or anti-VEGF therapy in the management of retinal arterial macroaneurysms
title_full Observation, laser photocoagulation or anti-VEGF therapy in the management of retinal arterial macroaneurysms
title_fullStr Observation, laser photocoagulation or anti-VEGF therapy in the management of retinal arterial macroaneurysms
title_full_unstemmed Observation, laser photocoagulation or anti-VEGF therapy in the management of retinal arterial macroaneurysms
title_short Observation, laser photocoagulation or anti-VEGF therapy in the management of retinal arterial macroaneurysms
title_sort observation laser photocoagulation or anti vegf therapy in the management of retinal arterial macroaneurysms
topic Retinal arterial macroaneurysm
Management
Clinical characteristics
Visual acuity
Central retinal thickness
url https://doi.org/10.1186/s12886-022-02641-2
work_keys_str_mv AT yuelinwang observationlaserphotocoagulationorantivegftherapyinthemanagementofretinalarterialmacroaneurysms
AT hongdu observationlaserphotocoagulationorantivegftherapyinthemanagementofretinalarterialmacroaneurysms
AT xinyuzhao observationlaserphotocoagulationorantivegftherapyinthemanagementofretinalarterialmacroaneurysms
AT lihuimeng observationlaserphotocoagulationorantivegftherapyinthemanagementofretinalarterialmacroaneurysms
AT youxinchen observationlaserphotocoagulationorantivegftherapyinthemanagementofretinalarterialmacroaneurysms